Delivery Order SPE2DR25D3401-SPE2DR26FL0PB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This firm fixed-price delivery order, valued at $7,047.29, was competitively awarded without set-aside designation and is scheduled for completion by August 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,302.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through the DLA's medical supply chain. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, and no set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,765.60 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This firm fixed-price delivery order is set to be completed by December 3, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded, non-set-aside contract under a larger indefinite delivery contract (IDC) vehicle. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,322.63 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors with a ceiling value of $2,287.74. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 26, 2025, and no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,416.62 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive, firm fixed-price delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injectors on September 3, 2025, with a ceiling value of $1,007.21 and an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed price delivery order represents a single-use contract with no set-aside designation. The award is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,798.97 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a discrete purchase under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,949.83 on December 1, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0PBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,050.33 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract is a firm fixed price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts. The company serves critical healthcare entities including the Defense Health Agency and U.S. Coast Guard through competitively awarded delivery orders featuring firm fixed pricing. The Zepbound supply order reflects the company's established capability to deliver specialty pharmaceuticals and supports DLA's medical supply chain operations in providing pharmaceutical commodities across multiple therapeutic domains to support military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 12/8/25 |